A cancer drug that washed out of clinical trials more than 15 years ago may be the key to slowing the progression of Parkinson’s disease, according to a Northwestern Medicine study.
Building on years of research and collaborations promoting optimal health and well-being among seniors, Feinberg has launched the Center for Applied Health Research on Aging.
A drug originally designed to help manage diabetes may also improve quality of life for patients with heart failure, according to a recent clinical trial.
High levels of folate, a B vitamin, can force glial nerve cells to transform back into undifferentiated stem cells, according to a new study published in the journal Stem Cells.
Funding has been announced for the first phase of an eight-year initiative to enable African hospitals to improve newborn survival by 50 percent, led by a consortium including Northwestern University.
Northwestern Medicine scientists have developed a new strategy to treat Parkinson’s disease by mitigating the effects of harmful genetic mutations, according to a recent study.
Second-year medical students shared results from their ongoing Area of Scholarly Concentration (AOSC) research projects at a recent poster session.
Northwestern University Feinberg School of Medicine received a record $534 million in research funding and awards during the 2018-2019 fiscal year.
The use of long-acting bronchodilators to treat asthma had no impact for some African-American children, according to a new study from Ann & Robert H. Lurie Children’s Hospital of Chicago and the Department of Pediatrics.
A new Northwestern Medicine study found an experimental drug did not lower hospitalization among patients suffering from heart failure with preserved ejection fraction.